Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Anja Krippner-Heidenreich

Senior Researcher
Anja is senior researcher in the group of Olaf Heidenreich.
Phone +31 65000 6430
  • HMX3 is a critical vulnerability in MECOM-negative KMT2A::MLLT3 acute myelomonocytic leukemia: ACUTE MYELOID LEUKEMIA

    • feb. 2025
    • Saioa, Arza-Apalategi, et al
    • Leukemia
  • Leukemic stem cells activate lineage inappropriate signalling pathways to promote their growth

    • dec. 2024
    • Sophie G., Kellaway, et al
    • Nature communications
  • Repurposing CD19-directed immunotherapies for pediatric t(8;21) acute myeloid leukemia

    • dec. 2024
    • Farnaz, Barneh, et al
    • Haematologica
  • Combining CRISPR-Cas9 and TCR exchange to generate a safe and efficient cord blood-derived T cell product for pediatric relapsed AML

    • apr. 2024
    • Vania, Lo Presti, et al
    • Journal for ImmunoTherapy of Cancer
  • Combining CRISPR-Cas9 and TCR exchange to generate a safe and efficient cord blood-derived T cell product for pediatric relapsed AML

    • apr. 2024
    • Vania Lo, Presti, et al
    • Journal for ImmunoTherapy of Cancer
View all publications